Guillermo de la Rosa

Dr. Guillermo de la Rosa

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2020 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KSKushal Suryamohan
Kushal Suryamohan
SKSajesh P. Krishnankutty
Sajesh P. Krishnankutty
JGJoseph Guillory
Joseph Guillory
MJMatthew Jevit
Matthew Jevit
MSMarkus S. Schröder
Markus S. Schröder
SSSomasekar Seshagiri
Somasekar Seshagiri
Snakebite envenoming is a serious and neglected tropical disease that kills ~100,000 people annually. High-quality, genome-enabled comprehensive characterization of toxin genes will facilitate development of effective humanized recombinant antivenom. We report a de novo near-chromosomal genome assembly of Naja naja, the Indian cobra, a highly venomous, medically important snake. Our assembly has a scaffold N50 of 223.35 Mb, with 19 scaffolds containing 95% of the genome. Of the 23,248 predicted protein-coding genes, 12,346 venom-gland-expressed genes constitute the ‘venom-ome’ and this included 139 genes from 33 toxin families. Among the 139 toxin genes were 19 ‘venom-ome-specific toxins’ (VSTs) that showed venom-gland-specific expression, and these probably encode the minimal core venom effector proteins. Synthetic venom reconstituted through recombinant VST expression will aid in the rapid development of safe and effective synthetic antivenom. Additionally, our genome could serve as a reference for snake genomes, support evolutionary studies and enable venom-driven drug discovery.

13 August 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
GRGuillermo de la Rosa
Guillermo de la Rosa
FOFelipe Olvera
Felipe Olvera
IAIrving G. Archundia
Irving G. Archundia
Bruno LomonteBruno Lomonte
Bruno Lomonte
AAAlejandro Alagón
Alejandro Alagón
GCGerardo Corzo
Gerardo Corzo
Antivenoms are fundamental in the therapy for snakebites. In elapid venoms, there are toxins, e.g. short-chain α-neurotoxins, which are quite abundant, highly toxic, and consequently play a major role in envenomation processes. The core problem is that such α-neurotoxins are weakly immunogenic, and many current elapid antivenoms show low reactivity towards them. We have previously developed a recombinant consensus short-chain α-neurotoxin (ScNtx) based on sequences from the most lethal elapid venoms from America, Africa, Asia, and Oceania. Here we report that an antivenom generated by immunizing horses with ScNtx can successfully neutralize the lethality of pure recombinant and native short-chain α-neurotoxins, as well as whole neurotoxic elapid venoms from diverse genera such as Micrurus, Dendroaspis, Naja, Walterinnesia, Ophiophagus and Hydrophis. These results provide a proof-of-principle for using recombinant proteins with rationally designed consensus sequences as universal immunogens for developing next-generation antivenoms with higher effectiveness and broader neutralizing capacity.

6 April 2018 in Amino Acids
Verified
Journal Article
Closed access
PDF file
GRGuillermo de la Rosa
Guillermo de la Rosa
Lilu Corrales-GarciaLilu Corrales-Garcia
Lilu Corrales-Garcia
XRXimena Rodriguez-Ruiz
Ximena Rodriguez-Ruiz
ELEstuardo Lopez-Vera
Estuardo Lopez-Vera
GCGerardo Corzo
Gerardo Corzo

9 September 2016 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
PDF file
HCHerlinda Clement
Herlinda Clement
VFVianey Flores
Vianey Flores
GRGuillermo de la Rosa
Guillermo de la Rosa
FZFernando Zamudio
Fernando Zamudio
AAAlejandro Alagon
Alejandro Alagon
GCGerardo Corzo
Gerardo Corzo
The cysteine-rich neurotoxins from elapid venoms are primarily responsible for human and animal envenomation; however, their low concentration in the venom may hamper the production of efficient elapid antivenoms. Therefore, the aim of the present study was to produce fully active elapid neurotoxic immunogens for elapid antivenom production. Cysteine-rich neurotoxins showed recombinant expression in two strains of E. coli, and were purified using affinity chromatography and reverse-phase HPLC (rpHPLC). The cDNA of the four disulfide-bridged peptide neurotoxin Mlat1 was cloned into a modified expression vector, pQE30, which was transfected into two different E. coli strains. The recombinant toxin (HisrMlat1) was found only in inclusion bodies in M15 strain cells, and in both inclusion bodies and cytoplasm in Origami strain cells. The HisrMlat1 from inclusion bodies from M15 cells was solubilized using guanidine hydrochloride, and then purified by rpHPLC. It showed various contiguous fractions having the same molecular mass, indicating that HisrMlat1 was oxidized after cell extraction forming different misfolded disulfide bridge arrangements without biological activity. In vitro folding conditions of the misfolded HisrMlat1 generated a biologically active HisrMlat1. On the other hand, the HisrMlat1 from the cytoplasm from Origami cells was already soluble, and then purified by HPLC. It showed a single fraction with neurotoxic activity; so, no folding steps were needed. The in vitro folded HisrMlat1 from M15 cells and the cytoplasmic soluble HisrMlat1from Origami cells were indistinguishable in their structure and neurotoxicity. Rabbit polyclonal antibodies raised up against biologically active HisrMlat1 recognized the native Mlat1 (nMlat1) from the whole venom of M. laticorallis. In addition, HisrMlat1 was recognized by horse polyclonal antibodies obtained from the immunization of elapid species from sub-Saharan Africa. HisrMlat1 shows increased biological activities compared to the native peptide, and may be used as an immunizing agent in combination with other toxic components such phospholipases type A2 for elapid antivenom production.

1 February 2017 in Peptides
Verified
Journal Article
Closed access
GRGuillermo de la Rosa
Guillermo de la Rosa
NPNina Pastor
Nina Pastor
AAAlejandro Alagón
Alejandro Alagón
GCGerardo Corzo
Gerardo Corzo

1 December 2018 in Toxicon
Verified
Journal Article
Closed access
GRGuillermo de la Rosa
Guillermo de la Rosa
FOFelipe Olvera
Felipe Olvera
ECEpifanio Cruz
Epifanio Cruz
DPDayanira Paniagua
Dayanira Paniagua
GCGerardo Corzo
Gerardo Corzo